Pharmacologically inhibition of autophagy by HCQ/wortmannin inhibits propionate‐induced autophagy in vitro, and HCQ treatment ameliorates obesity, hepatic steatosis and insulin resistance of the Acss3–/– mice in vivo. The gene discussed is ACSS3; the disease is obesity due to melanocortin 4 receptor deficiency.